A multicentric, single blind, parallel, randomized, phase-IV non-inferiority study to evaluate the immunogenicity and safety of BE's combined liquid pentavalent DTwP-rHepB-HIB vaccine administered to 6-8 week old healthy Indian infants at 6-10-14 weeks schedule in comparison with a marketed SIIL's Pentavac SD vaccine
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Hib-DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- Sponsors Biological E Limited
- 04 Oct 2011 New trial record